Roche Holding AG Logo

Roche Holding AG

A global leader in pharmaceuticals and diagnostics, pioneering personalized healthcare solutions.

RO | SW

Overview

Corporate Details

ISIN(s):
CH0012032048 (+1 more)
LEI:
549300U41AUUVOAAOB37
Country:
Switzerland
Address:
Grenzacherstr. 124, 4058 Basel
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Roche Holding AG is a global, research-based healthcare company operating through two primary divisions: Pharmaceuticals and Diagnostics. As one of the world's largest biotechnology companies, Roche is a leading provider of innovative cancer treatments and a key developer of medicines for viral infections and cardiometabolic diseases. The Diagnostics division focuses on providing in-vitro diagnostic tests and transformative solutions that support early detection, prevention, diagnosis, and treatment monitoring. By combining its strengths in both pharmaceuticals and diagnostics, Roche aims to advance personalized healthcare and improve patient outcomes worldwide through scientific innovation and digital health solutions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2004-12-31 00:00
Annual Report
Annual Report 2004
English 8.5 MB
2004-12-31 00:00
Annual Report
Jahresbericht 2004
German 8.8 MB
2004-04-22 00:00
Investor Presentation
Presentation to analysts First Quarter 2004 Basle, April 21, 2004
English 1.2 MB
2003-12-31 00:00
Annual Report
Annual Report 2003
English 8.4 MB
2003-12-31 00:00
Annual Report
Jahresbericht 2003
German 8.5 MB
2003-07-25 00:00
Investor Presentation
First Half 2003 Presentation to analysts
English 1.1 MB
2003-04-11 00:00
Investor Presentation
26 March 2003Roadshow USANew York
English 175.9 KB
2003-04-10 00:00
Investor Presentation
Company Presentation 2003
English 250.3 KB
2003-02-12 00:00
Investor Presentation
16 January 2003 Roadshow Germany
English 323.7 KB
2002-12-31 00:00
Annual Report
Annual Report 2002
English 9.3 MB
2002-12-31 00:00
Annual Report
Jahresbericht 2002
German 9.7 MB

Automate Your Workflow. Get a real-time feed of all Roche Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Roche Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-16 N/A Executive member Sell None 1,494,248.20 CHF
2025-02-07 N/A Non-Executive member Buy None 613,652.00 CHF
2024-07-26 N/A Non-Executive member Sell None 1,743,760.00 CHF
2024-07-25 N/A Non-Executive member Sell None 723,460.00 CHF
2024-06-21 N/A Executive member Sell None 2,220,432.00 CHF
2024-06-10 N/A Executive member Sell None 1,260,138.00 CHF
2024-05-29 N/A Non-Executive member Buy None 504,400.00 CHF

Peer Companies

Company Country Ticker View
MUROMACHI CHEMICALS INC. Logo
A diversified manufacturer of pharmaceuticals, chemical systems, health foods & functional materials.
Japan 4885
MYUNGMOON PHARM CO.,LTD Logo
Develops, manufactures, and commercializes prescription & OTC medicines for global markets.
South Korea 017180
Nanexa AB Logo
Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.
Sweden NANEXA
Nanobiotix Logo
Develops a first-in-class radioenhancer to amplify radiotherapy's effect directly within tumors.
France NANO
Nanoform Finland OYJ Logo
Pharma tech firm engineering nanoparticles to enhance drug performance and development.
Finland NANOFH
NanoGroup S.A. Logo
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
Poland NNG
NanoRepro AG Logo
Develops and distributes rapid diagnostic self-tests for early disease detection.
Germany NN6
NATAC Logo
Develops sustainable plant extracts for nutraceutical, pharma, food, and animal nutrition industries.
Spain NAT
Biotech R&D of natural ingredients for health and wellness solutions.
South Korea 168330
Naturland Holding PLC Logo
A Hungarian company providing full-scale pharmaceutical manufacturing from R&D to sales.
United Kingdom NATUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.